These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 12208106

  • 1. Proliferation activity in oral and cutaneous canine melanocytic tumours: correlation with histological parameters, location, and clinical behaviour.
    Millanta F, Fratini F, Corazza M, Castagnaro M, Zappulli V, Poli A.
    Res Vet Sci; 2002 Aug; 73(1):45-51. PubMed ID: 12208106
    [Abstract] [Full Text] [Related]

  • 2. PCNA and Ki67 proliferation markers as criteria for prediction of clinical behaviour of melanocytic tumours in cats and dogs.
    Roels S, Tilmant K, Ducatelle R.
    J Comp Pathol; 1999 Jul; 121(1):13-24. PubMed ID: 10373290
    [Abstract] [Full Text] [Related]

  • 3. Lack of prognostic significance of angiogenesis in canine melanocytic tumours.
    Cuitiño MC, Massone AR, Idiart JR.
    J Comp Pathol; 2012 Jul; 147(2-3):147-52. PubMed ID: 22520819
    [Abstract] [Full Text] [Related]

  • 4. Cyclooxygenase-2 expression is related with localization, proliferation, and overall survival in canine melanocytic neoplasms.
    Martínez CM, Peñafiel-Verdú C, Vilafranca M, Ramírez G, Méndez-Gallego M, Buendía AJ, Sánchez J.
    Vet Pathol; 2011 Nov; 48(6):1204-11. PubMed ID: 21292918
    [Abstract] [Full Text] [Related]

  • 5. COX-1 and COX-2 expression in canine cutaneous, oral and ocular melanocytic tumours.
    Pires I, Garcia A, Prada J, Queiroga FL.
    J Comp Pathol; 2010 Nov; 143(2-3):142-9. PubMed ID: 20207364
    [Abstract] [Full Text] [Related]

  • 6. Prognosis after surgical excision of canine melanomas.
    Bostock DE.
    Vet Pathol; 1979 Jan; 16(1):32-40. PubMed ID: 462717
    [Abstract] [Full Text] [Related]

  • 7. E-Cadherin Expression in Canine Melanocytic Tumors: Histological, Immunohistochemical, and Survival Analysis.
    Silvestri S, Porcellato I, Mechelli L, Menchetti L, Iussich S, De Maria R, Sforna M, Bongiovanni L, Brachelente C.
    Vet Pathol; 2020 Sep; 57(5):608-619. PubMed ID: 32578507
    [Abstract] [Full Text] [Related]

  • 8. [Developmental studies on melanoma of the skin and mouth mucosa of dogs].
    Frese K.
    Vet Pathol; 1978 Jul; 15(4):461-73. PubMed ID: 695220
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evaluation of Ki-67 expression in feline non-ocular melanocytic tumours.
    Sabattini S, Renzi A, Albanese F, Fantinati M, Rigillo A, Abramo F, Tornago R, Tortorella G, Massaro M, Pagano TB, Buchholz J, Bettini G.
    BMC Vet Res; 2018 Oct 12; 14(1):309. PubMed ID: 30314485
    [Abstract] [Full Text] [Related]

  • 11. Cyclooxygenase-2 expression is associated with infiltration of inflammatory cells in oral and skin canine melanomas.
    Silveira TL, Veloso ES, Gonçalves INN, Costa RF, Rodrigues MA, Cassali GD, Del Puerto HL, Pang LY, Argyle DJ, Ferreira E.
    Vet Comp Oncol; 2020 Dec 12; 18(4):727-738. PubMed ID: 32323423
    [Abstract] [Full Text] [Related]

  • 12. Canine balloon and signet-ring cell melanomas: a histological and immunohistochemical characterization.
    Cangul IT, van Garderen E, van der Linde-Sipman JS, van den Ingh TS, Schalken JA.
    J Comp Pathol; 2001 Dec 12; 125(2-3):166-73. PubMed ID: 11578133
    [Abstract] [Full Text] [Related]

  • 13. C-kit expression in canine mucosal melanomas.
    Newman SJ, Jankovsky JM, Rohrbach BW, LeBlanc AK.
    Vet Pathol; 2012 Sep 12; 49(5):760-5. PubMed ID: 21825314
    [Abstract] [Full Text] [Related]

  • 14. Tumor Thickness and Modified Clark Level in Canine Cutaneous Melanocytic Tumors.
    Silvestri S, Porcellato I, Mechelli L, Menchetti L, Rapastella S, Brachelente C.
    Vet Pathol; 2019 Mar 12; 56(2):180-188. PubMed ID: 30244658
    [Abstract] [Full Text] [Related]

  • 15. Immunohistochemical expression of MDR1-Pgp 170 in canine cutaneous and oral melanomas: pattern of expression and association with tumour location and phenotype.
    Finotello R, Monné Rodriguez JM, Vilafranca M, Altimira J, Ramirez GA, Haines A, Ressel L.
    Vet Comp Oncol; 2017 Dec 12; 15(4):1393-1402. PubMed ID: 27779366
    [Abstract] [Full Text] [Related]

  • 16. Canine cutaneous melanocytic tumours: significance of β-catenin and survivin immunohistochemical expression.
    Bongiovanni L, D'Andrea A, Porcellato I, Ciccarelli A, Malatesta D, Romanucci M, Della Salda L, Mechelli L, Brachelente C.
    Vet Dermatol; 2015 Aug 12; 26(4):270-e59. PubMed ID: 25962968
    [Abstract] [Full Text] [Related]

  • 17. Mast cells and angiogenesis in canine melanomas: malignancy and clinicopathological factors.
    Mukaratirwa S, Chikafa L, Dliwayo R, Moyo N.
    Vet Dermatol; 2006 Apr 12; 17(2):141-6. PubMed ID: 16515657
    [Abstract] [Full Text] [Related]

  • 18. Fascin-1 expression in canine cutaneous and oral melanocytic tumours.
    Yamada N, Mori T, Murakami M, Noguchi S, Sakai H, Akao Y, Maruo K.
    Vet Comp Oncol; 2012 Dec 12; 10(4):303-11. PubMed ID: 22236355
    [Abstract] [Full Text] [Related]

  • 19. Immunohistochemical expression of tenascin in melanocytic tumours of dogs.
    Sevastre B, van Ederen AM, Terlou M, Gruys E, Nederbragt H.
    J Comp Pathol; 2007 Jan 12; 136(1):49-56. PubMed ID: 17258226
    [Abstract] [Full Text] [Related]

  • 20. MIB-1 proliferative activity is a significant prognostic factor in primary thick cutaneous melanomas.
    Ramsay JA, From L, Iscoe NA, Kahn HJ.
    J Invest Dermatol; 1995 Jul 12; 105(1):22-6. PubMed ID: 7615970
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.